SCHEMBL4695047

SCHEMBL4695047

CNCc1ccc(CC(C)C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL643446 0.87 CHRM3 (0.65) CHRM3
SCHEMBL644974 0.85 CHRM3 (0.62) CHRM3
SCHEMBL3532704 0.83 CHRM3 (0.57) CHRM3
SCHEMBL266147 0.82 CHRM3 (0.80) CHRM3
SCHEMBL644985 0.81 CHRM3 (0.61) CHRM3
SCHEMBL4431076 0.81 CHRM3 (0.62) CHRM3
SCHEMBL644494 0.80 CHRM3 (0.58) CHRM3
SCHEMBL6017506 0.80 CHRM3 (0.62) CHRM3
SCHEMBL644196 0.80 CHRM3 (0.60) CHRM3
SCHEMBL645303 0.79 CHRM3 (0.65) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP claimed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO claimed